ما مدى موثوقية تألق المناعة النسيجية لمؤشر Ki-67 في سرطانات الثدي من الدرجة الثانية؟ دراسة ضمان جودة من المجموعة السويسرية للعمل لأطباء أمراض الثدي وأمراض النساء

درس فارغا وآخرون (Fri,) هذا السؤال.

www.synapsesocial.com/papers/69dc336c8bac30e30e9f54d3 — DOI: https://doi.org/10.1371/journal.pone.0037379

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Histopathologic Features and MIB-1 Labeling Indices in Recurrent and Nonrecurrent Meningiomas· 1999 · 59 citations
2. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation· 1983 · 2,830 citations
3. Quantitative immunohistochemical evaluation of MIB‐1 labeling index in adult soft‐tissue sarcomas by computer‐assisted image analysis· 2002 · 19 citations
4. Comparison of different scoring systems for immunohistochemical staining.· 1999 · 139 citations
5. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials· 2005 · 7,609 citations